Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients

The American Journal of Medicine

Volumn 67, Issue 2, 1979, Pages 277-286

  Grossman, Marc E ^a   Bickers, David R ^a   Poh Fitzpatrick, Maureen B ^a   Deleo, Vincent A ^a   Harber, Leonard C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; ETIOLOGY; LIVER BIOPSY; MAJOR CLINICAL STUDY; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; THERAPY;

EID: 0018779384     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(79)90403-0     Document Type: Article

References (50)

1. Studien über Porphyrie
2. Observations on porphyria cutanea tarda
3. Porphyrias as inborn errors of metabolism
4. Adult form of chronic porphyria with cutaneous manifestations; report of 17 additional cases
5. Cutaneous porphyria in Turkey
6. Acquired toxic porphyria cutanea tarda due to hexachlorobenzene
7. Porphyria cutanea tarda
8. Lupus erythematosus and porphyria
9. Porphyria cutanea tarda and diabetes
10. Porphyria cutanea tarda induced by estrogens
11. Porphyria cutanea tarda and estrogens
12. Estrogen-induced porphyria cutanea tarda
13. Industrially acquired porphyria
14. A health survey of workers in a 2,4-D and 2,4,5-T plant
15. Porphyria cutanea tarda associated with disinfectant misuse
16. Quantitative determination of porphobilinogen and porphyrins in urine and porphyrins in feces and erythrocytes
17. Direct spectrofluorometry of diluted erythrocytes and plasma a rapid diagnostic method in primary and secondary porphyrinemias
18. Analytical and preparative thin-layer chromatography of porphyrin methyl esters
19. Cutaneous porphyria in the adult
20. Porphyrin content of bone marrow and liver in the various forms of porphyria
21. Porphyria cutanea tarda in young women
22. Stilbestrol-induced porphyria; increase in hepatic δ-amino-levulinic acid synthetase
23. Uroporphyrin formation induced by chlorinated hydrocarbons (lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin); requirements for endogenous iron, protein synthesis, and drug-metabolizing activity
24. The effect of the porphyrogenic compound hexachlorobenzene on the activity of hepatic uroporphyrinogen decarboxylase in the rat
25. Iron metabolism in the porphyrias
26. δ-aminolevulinic acid synthetase. III. synergistic effect of chelated iron on induction
27. The role of iron in the pathogenesis of porphyria cutanea tarda
28. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase
29. An inherited enzymatic defect in porphyria cutanea tarda. Decreased uroporphyrinogen decarboxylase activity
30. Porphyria cutanea tarda in three generations of a single family
31. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda
32. Porphyria cutanea tarda symptomatica
33. Porphyria and photosensitivity
34. The treatment of porphyria cutanea tarda by venesection
35. Porphyria variegata. Study of a large kindred in the United States
36. A plasma porphyrin marker for variegate porphyria
37. Needle-like cytoplasmic inclusions in the liver in porphyria cutanea tarda
38. Hepatic fluorescence in porphyria cutanea tarda studies in fine needle aspiration biopsy smears
39. Allgemeinsymptome der späten Hautporphyrie (Porphyria Cutanea Tarda) als Hinweise für deren Behandlung
40. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda
41. Porphyria cutanea tarda; a study of the effect of phlebotomy
42. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relations to the phlebotomy-induced reduction of iron stores
43. Iron metabolism in porphyria cutanea tarda and in erythropoietic protoporphyria
44. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda
45. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects
46. Biochemical effects of chloroquine therapy in porphyria cutanea tarda
47. Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria
48. The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda
49. Treatment of porphyria cutanea tarda with chloroquine
50. The molecular basis of the action of chloroquine in porphyria cutanea tarda